The growing importance of starting the Drug Discovery process from natural-product-derived and synthetic small molecules is underlined by this article from Nature Reviews Chemistry – https://www.nature.com/articles/s41570-021-00313-1 – contributed by scientists from leading European institutions, including NAICONS.
NAICONS owns one of the widest and most important Strain Collection to allow such process plus an outstanding workflow to make this happen.